Habit Reversal Training for Tourette Syndrome

Waitlist Available
Led By Joseph F McGuire, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Upwithin 1 week after completion of hrt
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will explore how well youth with Tourette Syndrome respond to extinction learning (a type of therapy) and if this process can help treat TS.

Eligible Conditions
  • Tourette Syndrome
  • Habit Reversal Training
  • Tics


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1 week after completion of hrt
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1 week after completion of hrt for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tic severity as assessed by the Hopkins Motor and Vocal Tic Scale (HM/VTS)
Secondary outcome measures
Tic severity as assessed by the Yale Global Tic Severity Scale-Revised (YGTSS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Habit Reversal TrainingExperimental Treatment1 Intervention
Habit Reversal Training (HRT) is a multi-component evidence-based treatment for tics. It will be delivered over 4 two-hour sessions in an intensive format.
First Studied
Drug Approval Stage
How many patients have taken this drug
Habit Reversal Training

Find a site

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,157 Previous Clinical Trials
14,812,467 Total Patients Enrolled
7 Trials studying Tourette Syndrome
205 Patients Enrolled for Tourette Syndrome
Joseph F McGuire, PhDPrincipal Investigator
Johns Hopkins University
1 Previous Clinical Trials
50 Total Patients Enrolled
1 Trials studying Tourette Syndrome
50 Patients Enrolled for Tourette Syndrome

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any patients being recruited for this trial at present?

"Affirmative, clinicaltrials.gov displays that this medical trial is actively seeking participants. The study was initially posted on February 28th 2019 and the details were most recently modified on October 6 2022. Fifty patients across a single site are necessary for enrollment in the experiment."

Answered by AI

How many participants have been included in this investigation?

"Affirmative. According to information on clinicaltrials.gov, the trial is currently recruiting participants, having initially been posted on February 28th 2019 and updated most recently in October 6th 2022. The study seeks 50 patients from a single site."

Answered by AI

Is the age range for participants of this trial below 70 years old?

"According to the study's inclusion parameters, individuals between 8 and 17 years old are eligible for enrollment."

Answered by AI

Who is eligible to take part in this investigation?

"The current medical trial is seeking 50 participants aged 8 to 17 years old with moderate or greater tic severity. Other eligibility criteria include having received fewer than 4 previous sessions of HRT, being medication-free for the last two months before enrollment or on a stable dose of psychiatric drugs during that period."

Answered by AI
~4 spots leftby Sep 2024